A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

Severe combined immunodeficiency (SCID) can be detected through newborn bloodspot screening. In the UK, the National Screening Committee (NSC) requires screening programmes to be cost-effective at standard UK thresholds. To assess the cost-effectiveness of SCID screening for the NSC, a decision-tree...

Full description

Bibliographic Details
Main Authors: Alice Bessey, James Chilcott, Joanna Leaviss, Carmen de la Cruz, Ruth Wong
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:International Journal of Neonatal Screening
Subjects:
severe combined immunodeficiency
SCID
cost-effectiveness
economic
newborn screening
neonatal screening
Online Access:https://www.mdpi.com/2409-515X/5/3/28

Internet

https://www.mdpi.com/2409-515X/5/3/28

Similar Items